News Column

New Molecular Imaging Study Findings Reported from University of Oxford

June 27, 2014

By a News Reporter-Staff News Editor at Drug Week -- A new study on Molecular Imaging is now available. According to news originating from Oxford, United Kingdom, by NewsRx editors, the research stated, "Molecular imaging of tumour tissue focusses mainly on extracellular epitopes such as tumour angiogenesis or signal transduction receptors expressed on the cell membrane."

Our news journalists obtained a quote from the research from the University of Oxford, "However, most biological processes that define tumour phenotype occur within the cell. In this mini-review, an overview is given of the various techniques to interrogate intracellular events using molecular imaging with radiolabelled compounds."

According to the news editors, the research concluded: "Additionally, similar targeting techniques can be employed for radionuclide therapy using Auger electron emitters, and recent advances in Auger electron therapy are discussed."

For more information on this research see: Imaging the inside of a tumour: a review of radionuclide imaging and theranostics targeting intracellular epitopes. Journal of Labelled Compounds & Radiopharmaceuticals, 2014;57(4):310-316. Journal of Labelled Compounds & Radiopharmaceuticals can be contacted at: Wiley-Blackwell, 111 River St, Hoboken 07030-5774, NJ, USA. (Wiley-Blackwell -; Journal of Labelled Compounds & Radiopharmaceuticals -

The news correspondents report that additional information may be obtained from B. Cornelissen, University of Oxford, Dept. of Oncol, MRC CRUK Gray Inst Radiat Oncol & Biol, Oxford OX1 2JD, United Kingdom (see also Molecular Imaging).

Keywords for this news article include: Oxford, Europe, United Kingdom, Nanotechnology, Molecular Imaging, Emerging Technologies

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Drug Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters